The reliability and validity of lung cancer and melanoma clinical quality survival measures
CONCLUSIONS: Our results suggest that these cancer survival measures demonstrated adequate test-retest reliability and expected findings for the known-group validity analysis. If data limitations and feasibility challenges can be addressed, implementation of these quality measures may provide a survival metric used for oncology quality improvement efforts.PMID:37669902 | DOI:10.1111/1475-6773.14164
Source: Cell Research - Category: Cytology Authors: Emma Pendl-Robinson Keri L Calkins Samuel E Simon Kirsten Barrett Dmitriy Poznyak Source Type: research
More News: Cancer | Cancer & Oncology | Cytology | Epidemiology | Lung Cancer | Medicare | Melanoma | Non-Small Cell Lung Cancer | Skin Cancer | Small Cell Lung Cancer | Statistics | Study